Raymond James Downgrades Monopar Therapeutics (MNPR) to Outperform
Go back to Raymond James Downgrades Monopar Therapeutics (MNPR) to Outperform| (NASDAQ: MNPR) | Delayed: 113.04 +2.63 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.41 | 52 Week High | $ | |||
| Open | $109.04 | 52 Week Low | $ | |||
| Day High | $113.56 | P/E | N/A | |||
| Day Low | $107.78 | EPS | $ | |||
| Volume | 165,724 | |||||

